[Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)].
D000328:Adult; D000368:Aged; D002319:Cardiovascular System / Q000187:drug effects*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D013453:Sulfonylurea Compounds
Valeur thérapeutique d'un nouvel antidiabétique oral original à visée vasculaire: le gliclazide (1702 SE.